Related Experiment Video
Updated: Apr 17, 2026

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
Published on: March 8, 2024
High-risk liver transplant candidates: An ethical proposal on where to draw the line
Thomas D Schiano1, Tyler Bourgoise, Rosamond Rhodes
1Division of Liver Diseases, Department of Medicine, Mount Sinai Medical Center, New York, NY; Recanati/Miller Transplant Institute, Mount Sinai Medical Center, New York, NY; Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, NY.
Abstract:
In making liver transplantation (LT) listing decisions, transplant programs accept that very large differences in expected 5-year posttransplant survival should matter and that small differences in expected survival should not matter. To date, the transplant community has not explicitly addressed the difficult question of how to make decisions when the differences are less dramatic. Existing well-accepted transplant policies neither articulate a criterion for where to draw the line nor provide an ethical justification for distinguishing those who should not be eligible for transplantation from those who should be. Herein we analyze a case from our LT program that raises the issue of how much of a difference should separate the eligible from the ineligible. We explain how our ethical analysis is consistent with the Scientific Registry of Transplant Recipients cumulative sum metric for transplant center performance, the United Network for Organ Sharing standard of capping Model for End-Stage Liver Disease scores at 40 for listing purposes, and the longstanding tradition of allocating scarce medical resources in accordance with the principle of triage. We also discuss how subjectivity can influence judgments about likely outcomes. We conclude by calling for research to gather data that could make survival predictions objective and by proposing a policy that would make the treatment of all patients fair.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

